Haleon plc Share Price

Equities

HLN

GB00BMX86B70

Pharmaceuticals

Market Closed - London S.E. 16:35:07 19/07/2024 BST 5-day change 1st Jan Change
338.8 GBX -0.38% Intraday chart for Haleon plc +0.53% +5.33%

Financials

Sales 2024 * 11.41B 14.73B 1,141B Sales 2025 * 11.85B 15.3B 1,185B Capitalization 30.94B 39.94B 3,094B
Net income 2024 * 1.48B 1.91B 148B Net income 2025 * 1.68B 2.17B 168B EV / Sales 2024 * 3.39 x
Net Debt 2024 * 7.7B 9.94B 770B Net Debt 2025 * 6.95B 8.97B 695B EV / Sales 2025 * 3.2 x
P/E ratio 2024 *
21.4 x
P/E ratio 2025 *
18.8 x
Employees 25,408
Yield 2024 *
1.82%
Yield 2025 *
2.08%
Free-Float 81.7%
More Fundamentals * Estimated data
Dynamic Chart
1 day-0.38%
1 week+0.53%
Current month+5.02%
1 month+4.09%
3 months+3.99%
6 months+3.14%
Current year+5.33%
More quotes
1 week
329.50
Extreme 329.5
343.50
1 month
320.00
Extreme 320
343.50
Current year
308.37
Extreme 308.3696
371.20
1 year
308.37
Extreme 308.3696
371.20
3 years
241.17
Extreme 241.1735
371.20
5 years
241.17
Extreme 241.1735
371.20
10 years
241.17
Extreme 241.1735
371.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 21/07/21
Director of Finance/CFO 52 30/11/21
Chief Tech/Sci/R&D Officer - 15/12/21
Members of the board TitleAgeSince
Director/Board Member - 17/07/22
Director/Board Member 64 17/07/22
Director/Board Member 57 17/07/22
More insiders
Date Price Change Volume
19/07/24 338.8 -0.38% 14,282,440
18/07/24 340.1 +1.64% 10,298,280
17/07/24 334.6 +0.87% 7,609,485
16/07/24 331.7 -0.24% 11,305,820
15/07/24 332.5 -1.34% 7,028,890

Delayed Quote London S.E., July 19, 2024 at 04:35 pm

More quotes
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.388 GBP
Average target price
3.637 GBP
Spread / Average Target
+7.35%
Consensus